ALDEN CANCER THERAPY AS
Signals
- Negativ egenkapital 2024 Bokført egenkapital er negativ (−2,8 mill kr).
- Driftsunderskudd 2024 Siste driftsresultat er negativt (−1,9 mill kr).
ALDEN CANCER THERAPY AS is registered as a limited company in Bergen, Vestland with organisation number 912772438. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2013. Registered share capital is NOK 47,000, divided into 156 shares. The company's stated purpose is: “Utvikle metoder for behandling av kreft og andre sykdommer for kommersiell utnyttelse samt det som naturlig står i forbindelse med dette.”.
Key figures · 2024
Financial health · 2024
Solidity capped at Weak because equity is below NOK 100,000.
Who owns ALDEN CANCER THERAPY AS?
ALDEN CANCER THERAPY AS has 5 registered shareholders:
- YZ HOLDING AS 58.9%
- VESTLANDETS INNOVASJONSSELSKAP AS 30.4%
- STENER KVINNSLAND 3.6%
- OCEANVIEW VENTURE CAPITAL AS 3.6%
- MARCK INVEST AS 3.6%
Frequently asked questions about ALDEN CANCER THERAPY AS
Who owns ALDEN CANCER THERAPY AS?
YZ HOLDING AS is the largest registered owner, with 58.9%.
Who is the general manager of ALDEN CANCER THERAPY AS?
Karl Henning Kalland is registered as general manager of ALDEN CANCER THERAPY AS.
Where is ALDEN CANCER THERAPY AS based?
ALDEN CANCER THERAPY AS has its business address in Bergen.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.